129 related articles for article (PubMed ID: 11855679)
1. Lung tissue distribution after intravenous administration of grepafloxacin: comparative study with levofloxacin.
Yamamoto H; Koizumi T; Hirota M; Kaneki T; Ogasawara H; Yamazaki Y; Fujimoto K; Kubo K
Jpn J Pharmacol; 2002 Jan; 88(1):63-8. PubMed ID: 11855679
[TBL] [Abstract][Full Text] [Related]
2. Physiologically-based pharmacokinetic analysis of grepafloxacin.
Nakajima Y; Hattori K; Shinsei M; Matsunaga N; Iizasa H; Sasabe H; Akiyama H; Miyanmoto G; Nakashima E
Biol Pharm Bull; 2000 Sep; 23(9):1077-83. PubMed ID: 10993208
[TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolone concentrations in plasma, urine, and bile after oral administration in rats with renal failure: useful technique for long-term bile collection.
Mizuta K; Hishikawa S; Hirota M; Miyamoto G; Fujimura A; Hakamata Y; Kobayashi E
J Med; 2001; 32(5-6):311-20. PubMed ID: 11958277
[TBL] [Abstract][Full Text] [Related]
4. Distribution characteristics of grepafloxacin, a fluoroquinolone antibiotic, in lung epithelial lining fluid and alveolar macrophage.
Deguchi Y; Sun J; Tauchi Y; Sakai S; Morimoto K
Drug Metab Pharmacokinet; 2003; 18(5):319-26. PubMed ID: 15618751
[TBL] [Abstract][Full Text] [Related]
5. Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.
Rodvold KA; Danziger LH; Gotfried MH
Antimicrob Agents Chemother; 2003 Aug; 47(8):2450-7. PubMed ID: 12878504
[TBL] [Abstract][Full Text] [Related]
6. Differences in the hepatobiliary transport of two quinolone antibiotics, grepafloxacin and lomefloxacin, in the rat.
Sasabe H; Kato Y; Terasaki T; Tsuji A; Sugiyama Y
Biopharm Drug Dispos; 1999 Apr; 20(3):151-8. PubMed ID: 10211868
[TBL] [Abstract][Full Text] [Related]
7. Mechanism for the tissue distribution of grepafloxacin, a fluoroquinolone antibiotic, in rats.
Suzuki T; Kato Y; Sasabe H; Itose M; Miyamoto G; Sugiyama Y
Drug Metab Dispos; 2002 Dec; 30(12):1393-9. PubMed ID: 12433809
[TBL] [Abstract][Full Text] [Related]
8. Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects.
Gotfried MH; Danziger LH; Rodvold KA
Chest; 2001 Apr; 119(4):1114-22. PubMed ID: 11296178
[TBL] [Abstract][Full Text] [Related]
9. Interaction between levofloxacin and vancomycin in rats--study of serum and organ levels.
Mori H; Nakajima T; Nakayama A; Yamori M; Izushi F; Gomita Y
Chemotherapy; 1998; 44(3):181-9. PubMed ID: 9612608
[TBL] [Abstract][Full Text] [Related]
10. Distribution characteristics of levofloxacin and grepafloxacin in rat kidney.
Ito T; Yano I; Masuda S; Hashimoto Y; Inui K
Pharm Res; 1999 Apr; 16(4):534-9. PubMed ID: 10227708
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and ocular penetration of grepafloxacin in albino and pigmented rabbits.
Perez S; Solans C; Bregante MA; Pinilla I; García MA; Honrubia F
J Antimicrob Chemother; 2002 Oct; 50(4):541-5. PubMed ID: 12356799
[TBL] [Abstract][Full Text] [Related]
12. Alteration of pharmacokinetics of grepafloxacin in type 2 diabetic rats.
Watanabe M; Kobayashi M; Ogura J; Takahashi N; Yamaguchi H; Iseki K
J Pharm Pharm Sci; 2014; 17(1):25-33. PubMed ID: 24735760
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute renal failure and ganciclovir on the pharmacodynamics of levofloxacin-induced seizures in rats.
Ishiwata Y; Son K; Itoga Y; Yasuhara M
Biol Pharm Bull; 2007 Apr; 30(4):745-50. PubMed ID: 17409514
[TBL] [Abstract][Full Text] [Related]
14. Differential involvement of multidrug resistance-associated protein 1 and P-glycoprotein in tissue distribution and excretion of grepafloxacin in mice.
Sasabe H; Kato Y; Suzuki T; Itose M; Miyamoto G; Sugiyama Y
J Pharmacol Exp Ther; 2004 Aug; 310(2):648-55. PubMed ID: 15131241
[TBL] [Abstract][Full Text] [Related]
15. Carrier-mediated uptake of grepafloxacin, a fluoroquinolone antibiotic, by the isolated rat lung cells.
Sasabe H; Kato Y; Suzuki T; Itose M; Miyamoto G; Sugiyama Y
Drug Metab Pharmacokinet; 2005 Dec; 20(6):491-5. PubMed ID: 16415534
[TBL] [Abstract][Full Text] [Related]
16. [Levofloxacin concentrations in serum, sputum and lung tissue: evaluation of its efficacy according to breakpoint].
Fujita A; Miya T; Tanaka R; Hirayama S; Isaka H; Ono Y; Koshiishi Y; Goya T
Jpn J Antibiot; 1999 Nov; 52(11):661-6. PubMed ID: 10659442
[TBL] [Abstract][Full Text] [Related]
17. Effects of traditional Chinese medicines on pharmacokinetics of levofloxacin.
Hasegawa T; Yamaki K; Muraoka I; Nadai M; Takagi K; Nabeshima T
Antimicrob Agents Chemother; 1995 Sep; 39(9):2135-7. PubMed ID: 8540731
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic evaluation of amphotericin B in lung tissue: lung lymph distribution after intravenous injection and airspace distribution after aerosolization and inhalation of amphotericin B.
Koizumi T; Kubo K; Kaneki T; Hanaoka M; Hayano T; Miyahara T; Okada K; Fujimoto K; Yamamoto H; Kobayashi T; Sekiguchi M
Antimicrob Agents Chemother; 1998 Jul; 42(7):1597-600. PubMed ID: 9660990
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effects of fluoroquinolones on L-carnitine transport in placental cell line BeWo.
Hirano T; Yasuda S; Osaka Y; Asari M; Kobayashi M; Itagaki S; Iseki K
Int J Pharm; 2008 Mar; 351(1-2):113-8. PubMed ID: 17977676
[TBL] [Abstract][Full Text] [Related]
20. Intrapulmonary concentration of levofloxacin in patients with idiopathic pulmonary fibrosis.
Huang H; Wang Y; Jiang C; Lang L; Wang H; Chen Y; Zhao Y; Xu Z
Pulm Pharmacol Ther; 2014 Jun; 28(1):49-52. PubMed ID: 24211813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
